TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cassava Sciences ( (SAVA) ) has shared an update.
Cassava Sciences, Inc. has released a corporate presentation available in the ‘Investors’ section of its website. This presentation is part of a Form 8-K filing, but the information is not considered ‘filed’ under the Securities Exchange Act of 1934 and is not subject to its liabilities.
The most recent analyst rating on (SAVA) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Cassava Sciences stock, see the SAVA Stock Forecast page.
Spark’s Take on SAVA Stock
According to Spark, TipRanks’ AI Analyst, SAVA is a Neutral.
Cassava Sciences faces significant financial challenges with no revenue and ongoing operational losses, reflected in the low financial performance score. Technical indicators show bearish trends, and the negative P/E ratio emphasizes valuation concerns. However, the strategic license agreement with Yale University could offer future growth potential, though it currently holds minimal weight due to its speculative nature.
To see Spark’s full report on SAVA stock, click here.
More about Cassava Sciences
Average Trading Volume: 859,623
Technical Sentiment Signal: Sell
Current Market Cap: $104.3M
For detailed information about SAVA stock, go to TipRanks’ Stock Analysis page.